Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi Chugh

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Journal of Adolescent and Young Adult Oncology|January 5, 2023
Banking on Fertility Preservation: Financial Concern for Adolescent and Young Adult Cancer Patients Considering Oncofertility ServicesNina Jackson Levin, Chiu Yi Tan, Daria Stelmak, et al.
Journal of Communication in Healthcare|December 12, 2024
Experts of their own experience: adolescent and young adult cancer patients' advice-giving as a coping mechanismNicholas T Iannarino, Nina Francis-Levin, Julianna Corrao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2016
A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and LymphomasJeffrey R Infante, Philippe A Cassier, John F Gerecitano, et al.
Cancer Research|July 2, 2016
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell StatesElisabeth A Pedersen, Rajasree Menon, Kelly M Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
A Phase II Multi-Center Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic SarcomaBrittany L Siontis, John D Rice, Scott M Schuetze, et al.
Cancer|December 8, 2020
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcomaRashmi Chugh, Karla V Ballman, Lee J Helman, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2018
Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumoursOlivier Mir, Analia Azaro, Jaime Merchan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2010
Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trialRashmi Chugh, J Kyle Wathen, Shreyaskumar R Patel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2015
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcomaElizabeth J Davis, Rashmi Chugh, Lili Zhao, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Journal of Adolescent and Young Adult Oncology|January 5, 2023
Banking on Fertility Preservation: Financial Concern for Adolescent and Young Adult Cancer Patients Considering Oncofertility ServicesNina Jackson Levin, Chiu Yi Tan, Daria Stelmak, et al.
Journal of Communication in Healthcare|December 12, 2024
Experts of their own experience: adolescent and young adult cancer patients' advice-giving as a coping mechanismNicholas T Iannarino, Nina Francis-Levin, Julianna Corrao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2016
A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and LymphomasJeffrey R Infante, Philippe A Cassier, John F Gerecitano, et al.
Cancer Research|July 2, 2016
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell StatesElisabeth A Pedersen, Rajasree Menon, Kelly M Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
A Phase II Multi-Center Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic SarcomaBrittany L Siontis, John D Rice, Scott M Schuetze, et al.
Cancer|December 8, 2020
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcomaRashmi Chugh, Karla V Ballman, Lee J Helman, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2018
Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumoursOlivier Mir, Analia Azaro, Jaime Merchan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2010
Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trialRashmi Chugh, J Kyle Wathen, Shreyaskumar R Patel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2015
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcomaElizabeth J Davis, Rashmi Chugh, Lili Zhao, et al.
Pageof 13